Get started
Author

Ulrich Beyer

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy
2018 · F. Stephen Hodi, Marcus Ballinger, et al. · Journal of Clinical Oncology · 366
Liposomal encapsulated anti-cancer drugs
2005 · Ralf-Dieter Hofheinz, Senta Ulrike Gnad-Vogt, et al. · Anti-Cancer Drugs · 356
Drug-Polymer Conjugates Containing Acid-Cleavable Bonds
1999 · Felix Kratz, Ulrich Beyer, et al. · Critical Reviews in Therapeutic Drug Carrier Systems · 182
Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)
2007 · Nathan W Levin, Steven Fishbane, et al. · The Lancet · 159
Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||
1998 · Felix Kratz, Ulrich Beyer, et al. · Journal of Pharmaceutical Sciences · 155
Serum Proteins as Drug Carriers of Anticancer Agents: A Review
1998 · Felix Kratz, Ulrich Beyer · Drug Delivery · 153
PDF
Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly
2007 · Wladyslaw Sulowicz, Francesco Locatelli, et al. · Clinical Journal of the American Society of Nephrology · 136
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression
2016 · Jorge A. Quiroz, Paul Tamburri, et al. · JAMA Psychiatry · 134
PDF
Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution
1999 · Paula C.A. Rodrigues, Ulrich Beyer, et al. · Bioorganic & Medicinal Chemistry · 107
C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis
2008 · Iain C. Macdougall, Rowan Walker, et al. · Clinical Journal of the American Society of Nephrology · 103
Synthesis and in Vitro Efficacy of Transferrin Conjugates of the Anticancer Drug Chlorambucil
1998 · Ulrich Beyer, Thomas Roth, et al. · Journal of Medicinal Chemistry · 80
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial
2010 · F. Carrera, C. E. Lok, et al. · Nephrology Dialysis Transplantation · 77
Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial
2007 · Marian Klinger, Manual Arias, et al. · American Journal of Kidney Diseases · 76
A novel and selective sodium‐glucose cotransporter‐2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus
2015 · S. Ikeda, Y. Takano, et al. · Diabetes Obesity and Metabolism · 72
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study
2008 · B. Canaud, G. Mingardi, et al. · Nephrology Dialysis Transplantation · 71
PDF
Differences in the Intracellular Distribution of Acid-Sensitive Doxorubicin-Protein Conjugates in Comparison to Free and Liposomal Formulated Doxorubicin as Shown by Confocal Microscopy
2001 · Ulrich Beyer, Barbara Rothen-Rutishauser, et al. · Pharmaceutical Research · 62
Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration
2007 · Francesco Locatelli, Giuseppe Villa, et al. · Current Medical Research and Opinion · 55
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
2011 · S. D. Roger, F. Locatelli, et al. · Nephrology Dialysis Transplantation · 50
PDF
C.E.R.A. Maintains Stable Control of Hemoglobin in Patients with Chronic Kidney Disease on Dialysis when Administered Once Every Two Weeks
2007 · Bruce Spinowitz, Daniel W. Coyne, et al. · American Journal of Nephrology · 50
Antitumour activity of acid labile transferrin and albumin doxorubicin conjugates in in vitro and in vivo human tumour xenograft models
1997 · F. Kratz, I. Fichtner, et al. · European Journal of Cancer · 46
Albumin Conjugates of the Anticancer Drug Chlorambucil: Synthesis, Characterization, and In Vitro Efficacy
1998 · Felix Kratz, Ulrich Beyer, et al. · Archiv der Pharmazie · 44
Synthesis of new maleimide derivatives of daunorubicin and biological activity of acid labile transferrin conjugates
1997 · Felix Kratz, Ulrich Beyer, et al. · Bioorganic & Medicinal Chemistry Letters · 44
Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease
2007 · Anatole Besarab, Moro O. Salifu, et al. · Clinical Therapeutics · 39
Synthesis and Stability of Four Maleimide Derivatives of the Anticancer Drug Doxorubicin for the Preparation of Chemoimmunoconjugates.
1997 · Michael KRUGER, Ulrich BEYER, et al. · Chemical and Pharmaceutical Bulletin · 36
PDF
Preparation, Characterization and in Vitro Efficacy of Albumin Conjugates of Doxorubicin.
1998 · Felix KRATZ, Ulrich BEYER, et al. · Biological and Pharmaceutical Bulletin · 32
PDF
Works count: 77
Citation count: 3,005
H-index: 28
I10-index: 39
Year
Topic
Type